Biopsies are generally not classified as preventive care—they are diagnostic procedures used to investigate existing symptoms or abnormalities. Preventive care typically includes services designed to prevent disease or detect it before symptoms appear, such as vaccinations, screenings (mammograms, colonoscopies), blood pressure checks, and cholesterol tests.
A biopsy is performed after a concerning finding has already been identified through examination or imaging. For example, if a mammogram shows a suspicious lesion, a biopsy removes tissue samples to determine whether it's cancerous. Similarly, if a doctor palpates a thyroid nodule or detects an abnormal skin growth, a biopsy confirms the diagnosis.
However, the distinction matters for insurance coverage. Many health insurance plans cover preventive screenings at no cost under preventive care benefits, but biopsies—being diagnostic rather than preventive—typically fall under regular medical care and may require copayments or coinsurance. Some plans treat biopsies that follow up on preventive screenings more favorably, while others classify them separately.
The screening itself (like a colonoscopy) might be preventive, but if polyps are found and removed, or if a tissue sample is taken, those interventions become diagnostic or therapeutic rather than preventive. Understanding this classification helps patients anticipate potential out-of-pocket costs and explains why insurance coverage differs between the screening and any follow-up biopsy.